Skip to main content
Log in

Die Klug-entscheiden-Initiative der Deutschen Gesellschaft für Innere Medizin

Empfehlungen der Deutschen Gesellschaft für Endokrinologie und der Deutschen Gesellschaft für Geriatrie

The Choosing Wisely Initiative of the German Society of Internal Medicine

Recommendations of the German Society for Endocrinology and the German Society for Geriatrics

  • Schwerpunkt: Klug entscheiden
  • Published:
Der Internist Aims and scope Submit manuscript

Zusammenfassung

Positivliste

A. Nach osteoporosetypischen Frakturen soll bei älteren Patienten in der Regel eine spezifische Osteoporosetherapie eingeleitet werden. a. Osteoporose als Erkrankung des höheren Lebensalters soll diagnostiziert und behandelt werden (Empfehlung der Deutschen Gesellschaft für Geriatrie). B. Alle Patienten mit Diabetes mellitus sollen bei Einleitung einer medikamentösen Therapie eine spezifische Schulung erhalten. C. Allen Schwangeren soll eine Jodsupplementation angeboten werden. D. Bei jüngeren und therapierefraktären Patienten soll auch nach endokrinen Ursachen einer Bluthochdruckerkrankung gesucht werden. E. Jede unklare Hyperkalzämie soll abgeklärt werden.

Negativliste

A. Eine Testosteronsubstitution soll nicht aufgrund eines einzelnen erniedrigten Testosteronwerts ohne Klinik und Ursachenabklärung eingeleitet werden. B. Bildgebende Verfahren sollen erst nach Sicherung einer hormonellen Erkrankung eingesetzt werden. C. Ein Ultraschallscreening auf Schilddrüsenveränderungen bei älteren Menschen soll nicht durchgeführt werden. D. Eine Dauertherapie mit Levothyroxin bei Struma nodosa soll nicht durchgeführt werden. E. Eine Hydrokortisontherapie bei substitutionspflichtigen Patienten soll in relevanten Stresssituationen nicht ohne Dosisanpassung bleiben.

Abstract

Positive recommendations

A. After osteoporotic fractures in the elderly, as a rule specific antiosteoporotic therapy should be initiated. a. Osteoporosis as a disease of the elderly should be diagnosed and treated (recommendation of the German Society for Geriatrics). B. All patients with diabetes mellitus should complete a specific diabetes training program when antidiabetic drug medication is initiated. C. In Germany, all pregnant women should be advised to undertake iodine supplementation. D. Endocrine causes of hypertension should be ruled out in younger patients and in patients on multiple antihypertensive drugs. E. All unclear cases of hypercalcemia should be clarified.

Negative recommendations

A. Testosterone substitution therapy should not be initiated on the basis of only one measurement of a reduced testosterone level without clinical signs and clarification of the underlying cause. B. Imaging procedures should only be used after the existence of hormonal disease has been confirmed. C. Sonographic screening for thyroid disease is not advised in the elderly. D. Long-term therapy with levothyroxine for nodular goiter should be avoided. E. In relevant stress situations hydrocortisone replacement therapy should not be continued without dose adjustment in patients with adrenal or pituitary insufficiency.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Literatur

  1. Abood A, Vestergaard P (2013) Increasing incidence of primary hyperparathyroidism in Denmark. Dan Med J 60(2):A4567

    PubMed  Google Scholar 

  2. Ahn HS, Kim HJ, Welch HG (2014) Korea’s thyroid-cancer “epidemic” – screening and overdiagnosis. N Engl J Med 371:1765–1767

    Article  PubMed  Google Scholar 

  3. Grobe TG, Dörning H, Schwartz FW (2011) Schriftenreihe zur Gesundheitsanalyse, Band 6, BARMER GEK Arztreport. Schwerpunkt: Bildgebende Diagnostik – Computer- und Magnetresonanztomographie, Asgard Verlag, St. Augustin

  4. Bath SC, Steer CD, Golding J et al (2013) Effect of inadequate iodine status in UK pregnant women on cognitive outcomes in their children: results from the Avon longitudinal study of parents and children (ALSPAC). Lancet 382(9889):331–337

    Article  CAS  PubMed  Google Scholar 

  5. Beuschlein F, Hahner S, Meyer G et al (2013) Adrenal cortical insufficiency – a life threatening illness with multiple etiologies. Dtsch Arztebl Int 110:51–52

    Google Scholar 

  6. Blum MR, Bauer DC, Collet TH et al (2015) Thyroid studies collaboration. Subclinical thyroid dysfunction and fracture risk: a meta-analysis. JAMA 313(20):2055–2065

    Article  PubMed  PubMed Central  Google Scholar 

  7. Boren SA, Fitzner KA, Panhalkar PS et al (2009) Costs and benefits associated with diabetes education: a review of the literature. Diabetes Educ 35(1):72–96

    Article  PubMed  Google Scholar 

  8. Brambilla DJ, O’Donnell AB, Matsumoto AM et al (2007) Intraindividual variation in levels of serum testosterone and other reproductive and adrenal hormones in men. Clin Endocrinol (Oxf) 67:853–862

    Article  CAS  Google Scholar 

  9. Budnitz DS, Lovegrove MC, Shehab N et al (2011) Emergency hospitalizations for adverse drug events in older Americans. N Engl J Med 365(21):2002–2012

    Article  CAS  PubMed  Google Scholar 

  10. Colon-Emeric C, Kuchibhatla M, Pieper C, Hawkes W, Fredman L, Magaziner J, et al (2003) Long-term risk of incident vertebral fractures. The contribution of hip fracture to risk of subsequent fractures: data from two longitudinal studies. Osteoporos Int 14(11):879–883

    Article  Google Scholar 

  11. DVO-Leitlinie. http://www.dv-osteologie.org/dvo_leitlinien/osteoporose-leitlinie-2014. Zugegriffen: 13. Febr. 1016

  12. Eisenhofer G, Goldstein DS, Walther MM et al (2003) Biochemical diagnosis of pheochromocytoma: how to distinguish true- from false-positive test results. J Clin Endocrinol Metab 88:2656–2666

    Article  CAS  PubMed  Google Scholar 

  13. Funder JW, Carey RM, Fardella C et al (2008) Endocrine Society. Case detection, diagnosis, and treatment of patients with primary aldosteronism: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 93(9):3266–3281

    Article  CAS  PubMed  Google Scholar 

  14. http://www.krebsdaten.de/Krebs/DE/Content/Publikationen/Krebs_in_Deutschland/kid_2015/krebs_in_deutschland_2015.pdf. Zugegriffen: 13. Febr. 2016

  15. Grussendorf M, Reiners C, Paschke R, LISA Investigators et al (2011) Reduction of thyroid nodule volume by levothyroxine and iodine alone and in combination: a randomized, placebo-controlled trial. J Clin Endocrinol Metab 96(9):2786–2795

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Hadji P, Klein S, Häussler B et al (2013) Epidemiologie der Osteoporose – Bone Evaluation Study. Eine Analyse von Krankenkassen-Routinedaten. Dtsch Arztebl Int 110(4):52–57

    PubMed  PubMed Central  Google Scholar 

  17. Hamilton F, Carroll R, Hamilton W et al (2014) The risk of cancer in primary care patients with hypercalcaemia: a cohort study using electronic records. Br J Cancer 111(7):1410–1412

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Hahner S, Spinnler C, Fassnacht M et al (2015) High incidence of adrenal crisis in educated patients with chronic adrenal insufficiency: a prospective study. J Clin Endocrinol Metab 100(2):407–416

    Article  CAS  PubMed  Google Scholar 

  19. Hannemann A, Friedrich N, Haring R et al (2010) Thyroid function tests in patients taking thyroid medication in Germany: Results from the population-based Study of Health in Pomerania (SHIP). BMC Res Notes 3:227

    Article  PubMed  PubMed Central  Google Scholar 

  20. Hannemann A, Wallaschofski H (2012) Prevalence of primary aldosteronism in patient’s cohorts and in population-based studies – a review of the current literature. Horm Metab Res 44(3):157–162

    Article  CAS  PubMed  Google Scholar 

  21. Heidemann C, Du Y, Schubert I et al (2013) Prevalence and temporal trend of known diabetes mellitus: results of the german health interview and examination survey for adults (DEGS1). Bundesgesundheitsbl Gesundheitsforsch Gesundheitsschutz 56:668–677

    Article  CAS  Google Scholar 

  22. Hynes KL, Otahal P, Hay I et al (2013) Mild iodine deficiency during pregnancy is associated with reduced educational outcomes in the offspring: 9‑year follow-up of the gestational iodine cohort. J Clin Endocrinol Metab 98(5):1954–1962

    Article  CAS  PubMed  Google Scholar 

  23. Icks A, Arend W, Becker C (2013) Incidence of hip fractures in Germany, 1995–2010. Arch Osteoporos 8(1–2):139

    Google Scholar 

  24. Bundesministerium für Ernährung und Landwirtschaft Jodversorgung in Deutschland: Ergebnisse des aktuellen Jodmonitoring, Bundesministerium für Ernährung und Landwirtschaft. http://www.bmel.de/DE/Ernaehrung/GesundeErnaehrung/_Texte/DEGS_JodStudie.html. Zugegriffen: 13. Febr. 2016

  25. Johannsson G, Falorni A, Skrtic S et al (2015) Adrenal insufficiency: review of clinical outcomes with current glucocorticoid replacemet therapy. Clin Endocrinol (Oxf) 82(1):2–11

    Article  CAS  Google Scholar 

  26. Johnell O, Kanis JA, Oden A et al (2004) Fracture risk following an osteoporotic fracture. Osteoporos Int 15(3):175–179

    Article  CAS  PubMed  Google Scholar 

  27. Kanis JA, Johnell O, Oden A et al (2001) Ten year probabilities of osteoporotic fractures according to BMD and diagnostic thresholds. Osteoporos Int 12:989–995

    Article  CAS  PubMed  Google Scholar 

  28. Mammen JS, McGready J, Oxman R et al (2015) Thyroid hormone therapy and risk of thyrotoxicosis in community-resident older adults: findings from the baltimore longitudinal study of aging. Thyroid 25(9):979–986

    Article  CAS  PubMed  Google Scholar 

  29. Marcocci C, Saponaro F (2015) Epidemiology, pathogenesis of primary hyperparathyroidism: current data. Ann Endocrinol (Paris) 76(2):113–115

    Article  Google Scholar 

  30. Marshall D, Johnell O, Wedel H (1996) Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures. BMJ 312(7041):1254–1259

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  31. Meisinger C, Ittermann T, Wallaschofski H et al (2012) Geographic variations in the frequency of thyroid disorders and thyroid peroxidase antibodies in persons without former thyroid disease within Germany. Eur J Endocrinol 167(3):363–371

    Article  CAS  PubMed  Google Scholar 

  32. Monahan M, Boelaert K, Jolly K et al (2015) Costs and benefits of iodine supplementation for pregnant women in a mildly to moderately iodine-deficient population: a modelling analysis. Lancet Diabetes Endocrinol 3(9):715–722

    Article  PubMed  Google Scholar 

  33. Nieman LK, Biller BM, Findling JW et al (2008) The diagnosis of cushing’s syndrome: an endocrine society clinical practical guideline. J Clin Endocrinol Metab 93(5):1526–1540

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  34. Nieschlag E, Swerdloff R, Behre HM et al (2005) International Society of Andrology (ISA); International Society for the Study of the Aging Male (ISSAM); European Association of Urology (EAU). Investigation, treatment and monitoring of late-onset hypogonadism in males. ISA, ISSAM and EAU recommendations. Eur Urol 48(1):1–4

    Article  CAS  PubMed  Google Scholar 

  35. Nordrheinische Gemeinsame Einrichtung Disease-Management-Programme Qualitätssicherungsbericht 2012. https://www.kvno.de/downloads/quali/qualbe_dmp12.pdf. Zugegriffen: 13. Febr. 2016

    Google Scholar 

  36. Reincke M, Fischer E, Gerum S et al (2012) German Conn’s Registry-Else Kröner-Fresenius-Hyperaldosteronism Registry. Observational study mortality in treated primary aldosteronism: the German Conn’s registry. Hypertension 60(3):618–624

    Article  CAS  PubMed  Google Scholar 

  37. Remer T, Johner SA, Gärtner R et al (2010) Jodmangel im Säuglingsalter – ein Risiko für die kognitive Entwicklung. Dtsch Med Wochenschr 135(31–32):1551–1556

    Article  CAS  PubMed  Google Scholar 

  38. Rosner W, Hubert V, Endocrine Society (2010) Towards excellence in testosterone testing: A consensus statement. J Clin Endocrinol Metab 95:4542–4548

    Article  CAS  PubMed  Google Scholar 

  39. Rossi GP, Bernin G, Caliumi C et al (2006) A prospective study of the prevalence of primary aldosteronism in 1125 hypertensive patients. J Am Coll Cardiol 48:2293–2300

    Article  CAS  PubMed  Google Scholar 

  40. Selmer C, Olesen JB, Hansen ML et al (2014) Subclinical and overt thyroid dysfunction and risk of all-cause mortality and cardiovascular events: a large population study. J Clin Endocrinol Metab 99(7):2372–2382

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to J. Feldkamp.

Ethics declarations

Interessenkonflikt

J. Feldkamp, M. Schott, M. Gogol, M. Quinkler, M. Blüher, S. Diederich und M. Reincke geben an, dass kein Interessenkonflikt besteht.

Dieser Beitrag beinhaltet keine von den Autoren durchgeführten Studien an Menschen oder Tieren.

Additional information

Redaktion

M. Hallek, Köln

G. Hasenfuß, Göttingen

E. Märker-Hermann, Wiesbaden

C. Sieber, Nürnberg

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Feldkamp, J., Schott, M., Gogol, M. et al. Die Klug-entscheiden-Initiative der Deutschen Gesellschaft für Innere Medizin. Internist 57, 532–539 (2016). https://doi.org/10.1007/s00108-016-0072-4

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00108-016-0072-4

Schlüsselwörter

Keywords

Navigation